MdxHealth SA (MDXH)
NASDAQ
Closed
Aug 25, 2026
Day's Range
0.726652 wk Range
0.4000Overview - MDXH - MdxHealth SA
Key Statistics
Valuation
Enterprise Value
125.59M
P/E (Trailing)
‪-1.17‬
P/E (Forward)
‪-2.02‬
PEG Ratio
‪0.11‬
Price / Sales (TTM)
‪0.64‬
Price / Book
‪-2.03‬
EV / EBITDA
‪-8.41‬
Profitability
Gross Margin
‪60.66%‬
Profit Margin
‪-32.74%‬
Operating Margin
‪-18.74%‬
Return on Assets
‪-9.83%‬
Return on Equity
‪277.15%‬
Ownership
Shares Outstanding
51.36M
Float
43.38M
Short % of Shares Outstanding
‪2.74%‬
Held by Insiders
‪22.14%‬
Held by Institutions
‪45.18%‬
Price stats
Beta
‪-501,440.84‬
50-Day Avg
‪0.4978‬
200-Day Avg
‪2.27‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪$ 2.20‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MDXH - MdxHealth SA
Peers - MDXH - MdxHealth SA
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
Profile Summary - MDXH - MdxHealth SA
About
MdxHealth SA is a pioneering biotechnology company specializing in molecular diagnostics. The company's primary function is to improve patient outcomes by offering innovative diagnostic solutions for the early detection of cancer. MdxHealth's non-invasive tests aid in the accurate diagnosis and management of cancers,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
